Anticoagulant Therapy in Patients Hospitalized With COVID-19
Type
Journal articlePermalink
https://hdl.handle.net/10161/23907Published Version (Please cite this version)
10.1001/jamainternmed.2021.6212Publication Info
(n.d.). Anticoagulant Therapy in Patients Hospitalized With COVID-19. JAMA Internal Medicine. 10.1001/jamainternmed.2021.6212. Retrieved from https://hdl.handle.net/10161/23907.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Thomas Lee Ortel
Chief, Division of Hematology in the Department of Medicine
My research program investigates the molecular mechanisms whereby various congenital
and acquired abnormalities result in ‘dysfunctional’ hemostasis (i.e., hemorrhage
or thrombosis) to better understand the molecular mechanisms and interactions that
are necessary for normal hemostasis. We are particularly interested in the mechanisms
whereby antibodies and other inhibitors can interfere with normal hemostatic mechanisms.
Several projects extensively overlap and focus on the assembly
Lana Wahid
Assistant Professor of Medicine
Health Services Researcher, Clinical TrialistMedical Director of Duke's Early Phase
Research Unit (DEPRU)Associate Chief, Hospital-Based Clinical Trials & Research Program
Alphabetical list of authors with Scholars@Duke profiles.
Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info